Regulation of Src family kinases during colorectal cancer development and its clinical implications
- Authors
- Jin W.
- Issue Date
- May-2020
- Publisher
- MDPI AG
- Keywords
- Cancer stem cells; Colorectal cancer; Drug targeting; Epithelial; Mesenchymal transition; Metastasis; Src family kinases
- Citation
- Cancers, v.12, no.5
- Journal Title
- Cancers
- Volume
- 12
- Number
- 5
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/57406
- DOI
- 10.3390/cancers12051339
- ISSN
- 2072-6694
- Abstract
- Src family kinases (SFKs) are non-receptor kinases that play a critical role in the pathogenesis of colorectal cancer (CRC). The expression and activity of SFKs are upregulated in patients with CRC. Activation of SFKs promotes CRC cell proliferation, metastases to other organs and chemoresistance, as well as the formation of cancer stem cells (CSCs). The enhanced expression level of Src is associated with decreased survival in patients with CRC. Src-mediated regulation of CRC progression involves various membrane receptors, modulators, and suppressors, which regulate Src activation and its downstream targets through various mechanisms. This review provides an overview of the current understanding of the correlations between Src and CRC progression, with a special focus on cancer cell proliferation, invasion, metastasis and chemoresistance, and formation of CSCs. Additionally, this review discusses preclinical and clinical strategies to improve the therapeutic efficacy of drugs targeting Src for treating patients with CRC. © 2020 by the author. Licensee MDPI, Basel, Switzerland.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의예과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/57406)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.